Boehringer Ingelheim

Boehringer Ingelheim ranks among the top 20 pharmaceutical companies in the world. Its main activities are the research, development, production and marketing of new products of high therapeutic value for human and animal medicine

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Boehringer Ingelheim is a powerhouse of medical innovation focused on five major research areas: cardio-metabolic diseases, diseases of the central nervous system (CNS), immunology and inflammation, oncology, and respiratory diseases. Around the world, the company has research sites in Ridgefield, USA, in Biberach, Germany, in Vienna, Austria, in Kobe, Japan, and in Milan, Italy. The largest research site, in Biberach, is the centre of competence for CNS diseases, cardio-metabolic diseases and respiratory diseases.

Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.

Vision

Value through Innovation is the central concept of our corporate vision. Together with the corporate culture concept 'Lead & Learn', this is the driver of the corporate culture.

Values

Value through Innovation: The company has for generations adhered to this principle in all its activities. It is Boehringer Ingelheim's goal to act with long-term responsibility and in a value-based manner. Boehringer Ingelheim is guided in its corporate responsibility by the company's stated core principles.